MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2026 International Congress

    Subthalamic Nucleus Deep Brain Stimulation Impact on Language Network Connectivity

    D. Lench, E. Laramie, M. Sowlat, G. Revuelta, F. Rodriguez-Porcel (Charelston, USA)

    Objective: To evaluate the impact of subthalamic deep brain stimulation on language network connectivity in participants with Parkinson’s disease (PwPD) by comparing resting state functional…
  • 2026 International Congress

    Clinical Predictors of Cognitive Decline in Parkinson’s Disease: A Longitudinal Cohort Study

    I. Zhukova, M. Matveeva, N. Zhukova, E. Agasheva, D. Novotnyy, S. Shtaymets, Z. Sayfitdinkhuzhaev (Moscow, Russian Federation)

    Objective: To identify clinical predictors associated with progression of cognitive impairment in patients with Parkinson’s disease. Background: Cognitive impairment is a common non-motor manifestation of…
  • 2026 International Congress

    Intranasal Delivery of Berberine-Loaded Solid Lipid Nanoparticles Ameliorates Neuropathological and Behavioral Deficits in a Preclinical Alzheimer’s Model

    R. Rajput, V. Sharma (New Delhi, India)

    Objective: To evaluate the pharmacokinetic profile and neuroprotective efficacy of intranasally administered berberine-loaded solid lipid nanoparticles (BE-SLN) in a streptozotocin (STZ)-induced rat model of Alzheimer’s…
  • 2026 International Congress

    Evaluating the Relationship between Depression and Other Non-Motor Symptoms in Parkinson’s Disease

    TCM. Leung, S. Appel-Cresswell (Vancouver, Canada)

    Objective: Investigate the correlation between depression and other non-motor symptoms, such as cognitive impairment and gastrointestinal (GI) dysfunction in Parkinson’s disease (PD). Background: In addition…
  • 2025 International Congress

    Medication Administration Burden in Lewy Body Dementia Caregivers

    W. Ayele, J. Hemm, S. Mitchell Chen, E. Stevens, A. Taylor, K. Fargo, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)

    Objective: To evaluate medication administration burden among Lewy Body Dementia (LBD) family caregivers and associations with caregiver and care recipient characteristics. Background: Family caregivers of…
  • 2025 International Congress

    A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease

    A. Puig-Davi, A. Moreu-Valls, S. Martinez-Horta, G. Kulisevsky, J. Rodriguez-Antiguedad, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate the efficacy of Immersive Virtual Reality (IVR) and Computerized Cognitive Training (CCT) for mild cognitive impairment in Parkinson’s disease (PD-MCI) Background: PD-MCI…
  • 2025 International Congress

    Determinants of Cognitive Progression in Parkinson’s Disease: A Machine Learning Approach

    AJ. Hernández-Medrano, A. Cervantes-Arriaga, MF. Medina-Pérez, D. Ulloa-Hernández, MF. Velasco-Delgado, GA. Martin-Mafud, AE. López-Lobato, D. Náfate-Wences, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify clinical and sociodemographic factors associated with cognitive decline (CD) in PD using a Random Forests model, classifying people with PD (PwP) into…
  • 2025 International Congress

    Baseline cerebrospinal levels of p-tau and amyloid beta and striatal dopamine transporter binding predict mild cognitive impairment and dementia diagnosis in Parkinson’s disease

    L. Collins-Praino, A. Mcnamara, I. Baetu (Adelaide, Australia)

    Objective: To assess whether baseline measurements of neuroimaging and biofluid-based biomarkers predict diagnosis of mild cognitive impairment (MCI) and dementia at 5-year follow-up in early…
  • 2025 International Congress

    Variations of Self-Perceived Cognitive Changes by Ethnicity in Parkinson’s Disease Patients

    H. Lee, P. Parekh, A. Arroyo, I. Balbo, A. Fanning, R. Alcalay, J. Agin-Liebes (New York, USA)

    Objective: To study perceptions of cognitive function across ethnic groups by comparing a subjective rating with an objective assessment for patients with PD (PWP). Background:…
  • 2025 International Congress

    Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

    R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley